TradingView
AlenCiken
2020년 7월 17일 오전 10시 13분
enrolling patients in a Phase 1 #ClinicalTrial
NASDAQ:HTBX
60
설명
⋅
2020년 7월 17일 오전 10시 13분
We have recently begun enrolling patients in a Phase 1 #ClinicalTrial with a new #oncology candidate. PTX-35 is an antibody that targets an entirely novel receptor involved in the immune response to #cancer.
clinicaltrials.gov/ct2/show/NCT04430348
Fundamental Analysis
Trend Analysis
Chart Patterns
코멘트
더보기